List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 40 studies with search of: swine vaccines
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting A Study of Inactivated Swine-Origin A/H1N1 Influenza Vaccines in Healthy European Subjects Aged 3 to 17 Years
Conditions: Influenza;   Swine-origin A/H1N1 Influenza
Interventions: Biological: Swine A/H1N1 influenza vaccine (split virion, inactivated);   Biological: Swine A/H1N1 influenza vaccine (split virion, inactivated + Adjuvant)
2 Active, not recruiting A Study of Swine-origin A/H1N1 Influenza Vaccines in Healthy European Adults and the Elderly
Conditions: Influenza;   Swine-origin A/H1N1 Influenza
Intervention: Biological: Swine A/H1N1 influenza vaccine (split virion, inactivated)
3 Active, not recruiting A Study of Swine-origin A/H1N1 Influenza Vaccines in Healthy Europeans Children Aged 6 to 35 Months
Conditions: Influenza;   Swine-origin A/H1N1 Influenza
Interventions: Biological: Swine A/H1N1 influenza vaccine (split virion, inactivated);   Biological: Swine A/H1N1 influenza vaccine (split virion, inactivated + Adjuvant);   Biological: Swine A/H1N1 influenza vaccine (split virion, inactivated + adjuvant)
4 Recruiting Observational Safety Study of Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Egg Derived Vaccine
Conditions: Pandemic Influenza A (H1N1);   A New Flu Virus of Swine Origin
Intervention: Other: Non-intervention observational study
5 Active, not recruiting Single-blind, Dose-ranging Study of Novel Swine Influenza Virus Vaccine in Japanese Pediatric Subjects
Condition: Swine-Origin Influenza A H1N1 Virus
Intervention: Biological: Adjuvanted cell-derived, inactivated novel swine origin A/H1N1 monovalent subunit influenza virus vaccine
6 Recruiting Observational Study of Safety of Flu Cell Culture Derived Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Vaccine
Conditions: Novel Influenza A (H1N1);   A New Flu Virus of Swine Origin
Intervention: Other: Non-intervention observational study
7 Active, not recruiting Single-blind, Dose-ranging Study of Novel Swine Influenza Virus Vaccine in Japanese Adult Subjects
Condition: Influenza
Intervention: Biological: Adjuvanted cell-derived, inactivated novel swine origin A/H1N1 monovalent subunit influenza virus vaccine
8 Active, not recruiting Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Children, Adolescents and Adults (3 to 64 Years)
Condition: Influenza A/H1N1 2009
Intervention: Biological: Adjuvanted and un-adjuvanted influenza vaccines
9 Active, not recruiting Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Non-Elderly and Elderly Adults
Condition: A/H1N1 S-OIV Influenza
Intervention: Biological: Adjuvanted and un-adjuvanted influenza vaccines
10 Active, not recruiting Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Children (3 to < 9 Years)
Condition: A/H1N1 S-OIV Influenza
Intervention: Biological: Adjuvanted and un-adjuvanted influenza vaccines
11 Active, not recruiting Study of Swine-Origin A/H1N1 Influenza Non-Adjuvanted Vaccine in Healthy Adults in India
Conditions: Influenza;   Pandemic Influenza;   Influenza A Virus, H1N1 Subtype
Intervention: Biological: A/H1N1 pandemic influenza vaccine (non- adjuvanted)
12 Active, not recruiting Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects 18 or More Years of Age
Condition: Pandemic Influenza
Intervention: Biological: Monovalent A/H1N1 influenza vaccine
13 Active, not recruiting Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects 18 or More Years of Age
Condition: Pandemic Influenza
Intervention: Biological: Monovalent A/H1N1 influenza vaccine
14 Recruiting Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects From 6 Months to 17 Years of Age
Condition: Pandemic Influenza
Intervention: Biological: Monovalent A/H1N1 influenza vaccine
15 Not yet recruiting Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine (Egg-Derived) in Healthy Subjects From 6 Months to 17 Years of Age
Condition: Pandemic Influenza
Intervention: Biological: Monovalent A/H1N1 influenza vaccine
16 Recruiting Immunogenicity, Tolerability and Safety of One or Two Doses of an Adjuvanted Swine-origin A H1N1 Influenza Vaccine in Healthy Subjects 18 or More Years of Age Both Vaccinated and Not Yet Vaccinated Against Seasonal Influenza 2009/10
Condition: Pandemic Influenza Disease
Intervention: Biological: Monovalent A/H1N1 influenza vaccine
17 Completed Swine Flu (Novel Influenza A H1N1) Vaccine Study
Condition: Influenza
Interventions: Biological: Baxter Novel Influenza A H1N1 Whole Virus Vaccine;   Biological: GlaxoSmithKline Novel Influenza A H1N1 Split Virion Vaccine
18 Active, not recruiting Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older
Condition: Influenza Infection
Interventions: Biological: GSK2340273A;   Biological: GSK2340274A
19 Recruiting Immunogenicity and Safety of Inactivated H1N1 Swine-origin Influenza Monovalent Vaccine in Immunocompromised Children and Young Adults
Condition: H1N1 Pandemic Flu
Intervention:
20 Active, not recruiting A Study of Different Formulations of an A/H1N1 Pandemic Vaccine in Healthy Adults and the Elderly
Conditions: Influenza;   Swine-origin A/H1N1 Influenza
Interventions: Biological: Monovalent Subvirion A/H1N1 Influenza vaccine (7.5 µg of HA);   Biological: Monovalent Subvirion A/H1N1 Influenza vaccine (15 µg of HA);   Biological: Monovalent Subvirion A/H1N1 Influenza vaccine (30 µg of HA);   Biological: Normal saline solution (placebo)

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services